Aleta Biotherapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $3.6M
Latest Deal Amount
  • Investors
  • 2

Aleta Biotherapeutics General Information

Description

Developer of immuno-oncology drugs designed to help treat and cure tumour and cancer. The company's drugs transform cellular therapeutics to permit a broad spectrum of tumour types to be targeted including currently intractable solid tumours, enabling healthcare professionals to use such drugs to treat their patients in an effective and efficient manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 27 Strathmore Road
  • Natick, MA 01746
  • United States
+1 (508) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aleta Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 25-Jul-2016 $3.6M 00.00 000.00 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Platform Creation 01-Jan-2015 Completed Startup
To view Aleta Biotherapeutics’s complete valuation and funding history, request access »

Aleta Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
To view Aleta Biotherapeutics’s complete cap table history, request access »

Aleta Biotherapeutics Executive Team (3)

Name Title Board Seat Contact Info
Paul Rennert Ph.D Co-Founder, President and Chief Scientific Officer
Roy Lobb Ph.D Co-Founder and Director
Mark Leuchtenberger Executive Chairman
To view Aleta Biotherapeutics’s complete executive team members history, request access »

Aleta Biotherapeutics Board Members (2)

Name Representing Role Since
Eva-Lotta Allan Self Board Member 000 0000
Mark Leuchtenberger Aleta Biotherapeutics Executive Chairman 000 0000
To view Aleta Biotherapeutics’s complete board members history, request access »

Aleta Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aleta Biotherapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advent Life Sciences Venture Capital Minority 000 0000 000000 0
ABI LAB Accelerator/Incubator Minority 000 0000 000000 0
To view Aleta Biotherapeutics’s complete investors history, request access »